Physician

Mehul Ramesh Bhatt, MD

According to 2025 Medicare claims, Mehul Bhatt, MD (NPI: 1811199946) practices cardiology in the Marietta, GA market, with the plurality of this provider's patient population coming from Cobb, GA. This provider's primary affiliated billing organization is HEART AND VASCULAR CARE, LLC (NPI: 1144371576; TIN: 208089449) and primary practice location at 30188-6402.

Bhatt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,738 traditional Medicare patients, billed 8,864 HCPCS/CPT codes, and received $888,272 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,625 prescription claims across 1,061 beneficiaries totaling $1,400,855 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 26 claims. Open Payments data shows 40 records totaling $959. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $350,566 to $1,400,855. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,505 and ending at $7,450.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,995	7,874	$569,853
2016	2,028	8,860	$668,465
2017	2,220	8,960	$734,385
2018	2,303	10,209	$760,968
2019	2,138	9,801	$842,320
2020	1,745	8,217	$680,032
2021	1,722	7,768	$747,265
2022	1,512	6,772	$599,638
2023	1,656	8,592	$781,763
2024	1,738	8,864	$888,272

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	596	6,239	$350,566
2016	744	6,718	$484,536
2017	810	6,808	$619,992
2018	915	7,397	$714,782
2019	993	7,378	$843,292
2020	976	6,867	$922,807
2021	948	6,354	$885,886
2022	892	5,622	$1,017,899
2023	979	6,144	$1,220,555
2024	1,061	6,625	$1,400,855

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	172	$18,605
2016	N/R	186	$92,424
2017	N/R	75	$9,728
2018	N/R	27	$788
2019	N/R	39	$1,704
2020	N/R	25	$747
2021	N/R	17	$1,063
2022	N/R	26	$1,242
2023	N/R	26	$1,381
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	530	533	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	743	1,104	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	338	365	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	530	727	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	848	1,123	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	718	39,783	$769,216
Xarelto	Rivaroxaban	161	9,682	$180,506
Repatha Sureclick	Evolocumab	158	7,968	$156,318
Entresto	Sacubitril/Valsartan	58	3,855	$68,769
Farxiga	Dapagliflozin Propanediol	58	3,220	$59,020

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$933	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$26	ABIOMED
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mehul Ramesh Bhatt, MD?

Tedicare shows public-source Medicare data for Mehul Ramesh Bhatt, MD (NPI 1811199946), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mehul Ramesh Bhatt, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mehul Ramesh Bhatt, MD?

Mehul Ramesh Bhatt, MD is linked to HEART AND VASCULAR CARE, LLC (billing NPI 1144371576) in the available physician profile data.

Does Mehul Ramesh Bhatt, MD have Open Payments data?

Mehul Ramesh Bhatt, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.